SeaStar Medical Holding Corp — Form 8-K
Filed October 5, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 22/100
What the filing says
On October 2, 2026, SeaStar Medical entered into a letter agreement with warrant holders to exercise 854,002 warrants (originally issued June–August 2025 at $6.38–$7.62/share) at a reduced exercise price of $3.866/share, generating ~$3.3M gross proceeds. In exchange, SeaStar issued 1,708,004 new unregistered warrants in two series: (i) 854,002 5-year warrants at $3.616/share exercise price, and (ii) 854,002 18-month warrants at $3.616/share. H.C. Wainwright & Co. acted as placement agent. The company committed to file a resale registration statement within 30 days.
Why this rating
Routine warrant repricing/refinancing; $3.3M is ~45% of $7.3M market cap but dilution-heavy (1.7M new warrants issued). No fundamental business change.
See more from October 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.